Adipokines are predominantly secretory protein hormones from adipose tissue but may also originate in placenta and other organs. Cross-sectionally, we monitored maternal plasma concentration of adiponectin, resistin, and leptin and their mRNA expression in abdominal subcutaneous adipose tissue and placenta from preeclamptic (PE; n ϭ 15) and healthy pregnant (HP; n ϭ 23) women undergoing caesarean section. The study groups were similar in age and BMI, whereas HOMA-IR tended to be higher in the PE group. In fasting plasma samples, the PE group had higher concentrations of adiponectin (18.3 Ϯ 2.2 vs. 12.2 Ϯ 1.1 g/ml, P ϭ 0.011), resistin (5.68 Ϯ 0.41 vs. 4.65 Ϯ 0.32 ng/ml, P ϭ 0.028), and leptin (34.4 Ϯ 3.2 vs. 22.7 Ϯ 2.1 ng/ml, P ϭ 0.003) compared with the HP group. Adiponectin and leptin concentrations were still different between PE and HP after controlling for BMI and HOMA-IR, whereas resistin concentrations differed only after controlling for BMI but not HOMA-IR. We found similar mean mRNA levels of adiponectin, resistin, and leptin in abdominal subcutaneous adipose tissue in PE and HP women. When data were pooled from PE and HP women, resistin mRNA levels in adipose tissue also correlated with HOMA-IR (r ϭ 0.470, P ϭ 0.012) after controlling for BMI and pregnancy duration. Resistin mRNA levels in placenta were not significantly different between PE and HP, whereas leptin mRNA levels were higher in PE placenta compared with HP. Thus increased plasma concentrations of adiponectin and resistin in preeclampsia may not relate to altered expression levels in adipose tissue and placenta, whereas both plasma and placenta mRNA levels of leptin are increased in preeclampsia.adiponectin; resistin; leptin; pregnancy PREECLAMPSIA IS CHARACTERIZED BY HYPERTENSION, increased vascular resistance, proteinuria, edema, and coagulopathy and has been linked to maternal systemic endothelial cell dysfunction (43). Delivery of the placenta results in clinical resolution, and placenta is viewed as the essential organ in the development of preeclampsia (42). Increased risk of preeclampsia has been reported with increased obesity (37). Development of insulin resistance in the third trimester of pregnancy (21), together with adipose tissue accumulation (11), is a possible adaptation of the maternal metabolism to optimize fetal nutrition. Insulin resistance has a potential role in pregnancy-induced hypertension, and extensive insulin resistance is often observed during preeclampsia (45). Furthermore, placenta secretes a variety of hormones that may play a role in both gestational insulin resistance and preeclampsia.Adipose tissue has an endocrine function, secreting several metabolically active proteins, such as leptin, resistin, adiponectin, TNF-␣, and IL-6, termed adipokines (50). During pregnancy, the placenta is an additional source of adipokines like leptin and resistin (17, 58). The antidiabetic and antiatherogenic properties of adiponectin are well documented (6), and in contrast to other adipokines, plasma adiponectin levels are ...